You are here

A Cancer Vaccine for Ovarian and Breast Cancer

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R41CA107590-01
Agency Tracking Number: CA107590
Amount: $605,355.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Timeline
Solicitation Year: 2004
Award Year: 2004
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
EPIMMUNE, INC. 5820 NANCY RIDGE DR, STE 100
San Diego, CA 92121
United States
DUNS: N/A
HUBZone Owned: Unavailable
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
  Ishioka
 (858) 860-2525
 GISHIOKA@EPIMMUNE.EDU
Business Contact
Phone: (858) 860-2553
Email: BDEVAERE@EPIMMUNE.COM
Research Institution
N/A
Abstract

DESCRIPTION (provided by applicant): The overall objective of this STTR program is to develop an effective cancer vaccine based on class II T cell epitopes derived from four tumor-associated antigens (TAAs) that are commonly over-expressed in ovary-an

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government